18 June 2025 - National health care institute Zorginstituut Nederland has scrapped several cancer inhibiting drugs from the basic health care package for specific groups of cancer sufferers, saying they do not work and are putting too much financial pressure on the system.

The institute based its conclusion on new international research, which it claims showed that PARP inhibitors, which help repair damaged DNA, do not lead to a better quality of life or prolong life in people whose cancer is not linked to a genetic defect.

Read Dutch News article